ArticleJournal of inflammation research2026

Real-World Patterns of Immunomodulator Use in Patients with Inflammatory Bowel Disease Receiving Biologic Therapy Under a 54-Week Reimbursement Cap: A 12-Year Retrospective Single-Center Cohort from Taiwan.

Wei-Chen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.